PAIGE SIMONS: Open Payments
NPI 1851923684 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 40 payments from 12 companies in 2025. Trend: 2023 $514 · 2024 $565 · 2025 $978
Food & beverage: $893Education: $85
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $322 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $154 |
| Novartis Pharmaceuticals Corporation | 4 | $122 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| Organon LLC | 4 | $70 |
| UCB, Inc. | 3 | $66 |
| Galderma Laboratories, L.P. | 1 | $41 |
| ABBVIE INC. | 2 | $39 |
| Janssen Biotech, Inc. | 2 | $33 |
| LEO Pharma Inc. | 1 | $20 |
Products named: DUPIXENT, VTAMA, ILUMYA, Bimzelx, COSENTYX, NEMLUVIO, TREMFYA, LIBTAYO.
Industry payments across TX — which companies pay providers there.
